Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease

Expert Opinion on Pharmacotherapy
Paul RolanKw Johnson

Abstract

Ibudilast is a relatively nonselective phosphodiesterase inhibitor which has been marketed for almost 20 years in Japan for treating asthma. More recently it has been found to have anti-inflammatory activity in both the peripheral immune system and in the CNS via glial cell attenuation. This CNS-directed anti-inflammatory activity is of potential use in the treatment of multiple sclerosis, neuropathic pain, and in the improved efficacy and safety of opioids by decreasing opioid tolerance, withdrawal and reinforcement. Its suitable pharmacokinetics and generally good tolerability make it a promising potential treatment for these conditions.

Associated Clinical Trials

References

Jan 1, 1992·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·A KawasakiS Yano
Jan 1, 1989·International Archives of Allergy and Applied Immunology·H OhtsuT Takishima
May 29, 1998·Journal of Neurochemistry·A YoshiokaD Pleasure
Dec 22, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J ChiharaT Yamamoto
Mar 15, 2001·Neuroscience Research·P Song, Z Q Zhao
Apr 23, 2003·Trends in Pharmacological Sciences·Antonello BonciNicola B Mercuri
Oct 9, 2004·Multiple Sclerosis : Clinical and Laboratory Research·Juan FengYasuto Itoyama
Nov 30, 2005·Life Sciences·Zheng HuangKazuhito Noguchi
May 6, 2006·European Journal of Pharmacology·Lucien C D GibsonSimon J Mackenzie
Jun 28, 2007·Expert Opinion on Investigational Drugs·Annemarie LedeboerKirk W Johnson
Oct 30, 2007·Nature Neuroscience·Christian S Lobsiger, Don W Cleveland
Oct 30, 2007·Nature Neuroscience·Costantino Iadecola, Maiken Nedergaard
Jan 8, 2008·Neuron Glia Biology·Annemarie LedeboerKirk W Johnson
Jul 5, 2008·Brain, Behavior, and Immunity·Mark R HutchinsonLinda R Watkins
Oct 22, 2008·Brain, Behavior, and Immunity·Mark R HutchinsonKirk W Johnson
Nov 27, 2008·British Journal of Clinical Pharmacology·Paul RolanKirk W Johnson
Dec 20, 2008·Nature Reviews. Neuroscience·Erin D Milligan, Linda R Watkins
Jun 3, 2009·Brain, Behavior, and Immunity·Sondra T BlandKirk W Johnson
Jun 11, 2009·British Journal of Pharmacology·Katharine H Banner, Neil J Press

❮ Previous
Next ❯

Citations

Apr 3, 2013·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Pradeep Chopra, Mark S Cooper
Nov 3, 2010·The Journal of Clinical Investigation·Gillian Burgess, Dic Williams
Dec 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jaclyn M SchwarzStaci D Bilbo
Aug 10, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yuqiang ShiShao-Jun Tang
Dec 12, 2013·CNS Drugs·Leandro Francisco Silva Bastos, Márcio Matos Coelho
Nov 12, 2014·Translational Psychiatry·J L JohnsonM R Hutchinson
Oct 15, 2013·Journal of Injury & Violence Research·Mohsen ZhalehGhasem Saki
Oct 30, 2014·Pain Practice : the Official Journal of World Institute of Pain·Martin F BjurstromCharles A Griffis
Jan 15, 2014·The Journal of Pain : Official Journal of the American Pain Society·Amanda EllisLinda R Watkins
Jan 19, 2016·Current Pain and Headache Reports·Amy W Voigt, Harry J Gould
Aug 5, 2015·Nature Reviews. Rheumatology·Geoffrey Littlejohn
Jul 29, 2015·Brain, Behavior, and Immunity·Pierluca CoiroAnna Dunaevsky
May 13, 2015·Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses·Sarah E GironJoseph F Burkard
Sep 18, 2015·Lancet Neurology·Hans-Christoph DienerDagny Holle
Nov 13, 2013·Addiction Biology·Richard L BellHoward C Becker
Sep 15, 2012·Medical Hypotheses·Ryan JallehMark R Hutchinson
May 14, 2014·Neuroscience and Biobehavioral Reviews·Vinod TiwariSrinivasa N Raja
Mar 19, 2013·European Journal of Pharmacology·Joanna MikaBarbara Przewlocka
Feb 5, 2013·European Journal of Pharmacology·Sarah E SniderPatrick M Beardsley
May 19, 2016·Expert Review of Clinical Immunology·Vikram Bhise, Suhayl Dhib-Jalbut
Jun 9, 2016·Journal of Clinical Psychopharmacology·Dustin Z DeYoungSteven J Shoptaw
Aug 9, 2016·Expert Opinion on Investigational Drugs·Andrew D GoodmanAndrew D Smith
Feb 6, 2014·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Michael D Scofield, Peter W Kalivas
Mar 1, 2014·Nature Reviews. Immunology·Peter M GraceLinda R Watkins
May 4, 2018·Expert Opinion on Investigational Drugs·Sarah S Ch'ng, Andrew J Lawrence
May 27, 2017·Beilstein Journal of Organic Chemistry·Aleksey Yu Vorob'evVyacheslav G Shubin
Feb 28, 2020·Anaesthesia and Intensive Care·Jessica Sy Lim, Peter Ca Kam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.